M&A Deal Summary

ANI Pharmaceuticals Acquires Novitium Pharma

On March 9, 2021, ANI Pharmaceuticals acquired life science company Novitium Pharma for 164M USD

Acquisition Highlights
  • This is ANI Pharmaceuticals’ 12th transaction in the Life Science sector.
  • This is ANI Pharmaceuticals’ largest (disclosed) transaction.
  • This is ANI Pharmaceuticals’ 11th transaction in the United States.
  • This is ANI Pharmaceuticals’ 3rd transaction in New Jersey.

M&A Deal Summary
Date 2021-03-09
Target Novitium Pharma
Sector Life Science
Buyer(s) ANI Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 164M USD
Advisor(s) Leerink Partners LLC (Financial)
Orrick (Legal)

Target

Novitium Pharma

East Windsor, New Jersey, United States
website
With operations in East Windsor, New Jersey, and Chennai, India, Novitium Pharma is a U.S.-based pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The Company, founded in 2016, by Samy Shanmugam, Chad Gassert, and Vijay Thorappadi, has since developed a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ANI Pharmaceuticals

Baudette, Minnesota, United States

website

Category Company
Founded 2001
Sector Life Science
Employees369
Revenue 208M USD (2020)
DESCRIPTION

ANI Pharmaceuticals is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI has several ANDAs pending FDA approval and in various stages of development. ANI Pharmaceuticals was formed in 2001 and is based in Baudette, Minnesota.

DEAL STATS #
Overall 14 of 14
Sector (Life Science) 12 of 12
Type (Add-on Acquisition) 2 of 2
State (New Jersey) 3 of 3
Country (United States) 11 of 11
Year (2021) 1 of 1
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-09 Amerigen Pharmaceuticals - Commercial and Pipeline Generic Products

Suzhou, China

Amerigen Pharmaceuticals' Commercial and Pipeline Generic Products includes a U.S. portfolio of 23 generic products.

Buy $53M
Mergr

Product

Company

Legal